CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,312 | 0 | ||
| 2024-11-07 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +4,688 | $19.02 | $89K | 18,188 |
| 2024-11-07 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −4,688 | $65.00 | $305K | 13,500 |
| 2024-11-07 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Stock Options (Right to buy) 10b5-1 | −4,688 | 14,062 | ||
| 2024-11-06 | Cramer Pamela J. Chief Human Resources Officer | Option exercise 10b5-1 | +4,687 | $19.02 | $89K | 18,187 |
| 2024-11-06 | Cramer Pamela J. Chief Human Resources Officer | Sale 10b5-1 | −4,687 | $60.00 | $281K | 13,500 |
| 2024-11-06 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Stock Options (Right to buy) 10b5-1 | −4,687 | 18,750 | ||
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise 10b5-1 | +15,000 | $22.93 | $344K | 18,000 |
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise 10b5-1 | +9,250 | $21.37 | $198K | 27,250 |
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise 10b5-1 | +7,501 | $18.99 | $142K | 34,751 |
| 2024-09-17 | GOOD JENNIFER L Director | Sale 10b5-1 | −31,751 | $52.40 | $1.7M | 3,000 |
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 0 | ||
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise · Stock Option (right to buy) 10b5-1 | −9,250 | 0 | ||
| 2024-09-17 | GOOD JENNIFER L Director | Option exercise · Stock Option (right to buy) 10b5-1 | −7,501 | 0 | ||
| 2024-09-10 | TETRAULT LYNN A. Director | Option exercise 10b5-1 | +10,000 | $4.15 | $42K | 13,000 |
| 2024-09-10 | TETRAULT LYNN A. Director | Option exercise 10b5-1 | +7,501 | $18.99 | $142K | 20,501 |
| 2024-09-10 | TETRAULT LYNN A. Director | Sale 10b5-1 | −8,490 | $49.05 | $416K | 12,011 |
| 2024-09-10 | TETRAULT LYNN A. Director | Sale 10b5-1 | −8,661 | $50.20 | $435K | 3,350 |
| 2024-09-10 | TETRAULT LYNN A. Director | Sale 10b5-1 | −350 | $50.60 | $18K | 3,000 |
| 2024-09-10 | TETRAULT LYNN A. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 |
Page 22 of 36 · 701 trades